Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)
NCT02567721
·
clinicaltrials.gov ↗
COMPLETED
Status
11530
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
OTHER:
Vaccine safety surveillance
Sponsor
GlaxoSmithKline
Collaborators
[object Object]